6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      High-throughput genetic engineering of nonmodel and undomesticated bacteria via iterative site-specific genome integration

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Efficient genome engineering is critical to understand and use microbial functions. Despite recent development of tools such as CRISPR-Cas gene editing, efficient integration of exogenous DNA with well-characterized functions remains limited to model bacteria. Here, we describe serine recombinase–assisted genome engineering, or SAGE, an easy-to-use, highly efficient, and extensible technology that enables selection marker–free, site-specific genome integration of up to 10 DNA constructs, often with efficiency on par with or superior to replicating plasmids. SAGE uses no replicating plasmids and thus lacks the host range limitations of other genome engineering technologies. We demonstrate the value of SAGE by characterizing genome integration efficiency in five bacteria that span multiple taxonomy groups and biotechnology applications and by identifying more than 95 heterologous promoters in each host with consistent transcription across environmental and genetic contexts. We anticipate that SAGE will rapidly expand the number of industrial and environmental bacteria compatible with high-throughput genetics and synthetic biology.

          Abstract

          Abstract

          Bacteriophage-derived tools enable simple, host-independent construction of complex genetically modified bacterial libraries.

          Related collections

          Most cited references80

          • Record: found
          • Abstract: found
          • Article: not found

          A bright monomeric green fluorescent protein derived from Branchiostoma lanceolatum

          Despite the existence of fluorescent proteins spanning the entire visual spectrum, the bulk of modern imaging experiments continue to rely on variants of the green fluorescent protein derived from Aequorea victoria. Meanwhile, a great deal of recent effort has been devoted to engineering and improving red fluorescent proteins, and relatively little attention has been given to green and yellow variants. Here we report a novel monomeric yellow-green fluorescent protein, mNeonGreen, which is derived from a tetrameric fluorescent protein from the cephalochordate Branchiostoma lanceolatum. This fluorescent protein is the brightest monomeric green or yellow fluorescent protein yet described, performs exceptionally well as a fusion tag for traditional imaging as well as stochastic single-molecule superresolution imaging, and is an excellent FRET acceptor for the newest generation of cyan fluorescent proteins.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A One Pot, One Step, Precision Cloning Method with High Throughput Capability

            Current cloning technologies based on site-specific recombination are efficient, simple to use, and flexible, but have the drawback of leaving recombination site sequences in the final construct, adding an extra 8 to 13 amino acids to the expressed protein. We have devised a simple and rapid subcloning strategy to transfer any DNA fragment of interest from an entry clone into an expression vector, without this shortcoming. The strategy is based on the use of type IIs restriction enzymes, which cut outside of their recognition sequence. With proper design of the cleavage sites, two fragments cut by type IIs restriction enzymes can be ligated into a product lacking the original restriction site. Based on this property, a cloning strategy called ‘Golden Gate’ cloning was devised that allows to obtain in one tube and one step close to one hundred percent correct recombinant plasmids after just a 5 minute restriction-ligation. This method is therefore as efficient as currently used recombination-based cloning technologies but yields recombinant plasmids that do not contain unwanted sequences in the final construct, thus providing precision for this fundamental process of genetic manipulation.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Multigene editing in the Escherichia coli genome via the CRISPR-Cas9 system.

              An efficient genome-scale editing tool is required for construction of industrially useful microbes. We describe a targeted, continual multigene editing strategy that was applied to the Escherichia coli genome by using the Streptococcus pyogenes type II CRISPR-Cas9 system to realize a variety of precise genome modifications, including gene deletion and insertion, with a highest efficiency of 100%, which was able to achieve simultaneous multigene editing of up to three targets. The system also demonstrated successful targeted chromosomal deletions in Tatumella citrea, another species of the Enterobacteriaceae, with highest efficiency of 100%.
                Bookmark

                Author and article information

                Contributors
                Role: ConceptualizationRole: Formal analysisRole: Funding acquisitionRole: InvestigationRole: MethodologyRole: Project administrationRole: ResourcesRole: SupervisionRole: ValidationRole: VisualizationRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: InvestigationRole: Methodology
                Role: Formal analysisRole: InvestigationRole: ResourcesRole: Validation
                Role: Formal analysisRole: Investigation
                Role: InvestigationRole: Validation
                Role: InvestigationRole: Resources
                Role: Validation
                Role: ConceptualizationRole: MethodologyRole: Writing - review & editing
                Role: Methodology
                Role: ConceptualizationRole: InvestigationRole: ResourcesRole: Writing - review & editing
                Role: ConceptualizationRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: SupervisionRole: Writing - original draftRole: Writing - review & editing
                Role: ConceptualizationRole: Data curationRole: Formal analysisRole: Funding acquisitionRole: MethodologyRole: Project administrationRole: ResourcesRole: SoftwareRole: SupervisionRole: Writing - original draftRole: Writing - review & editing
                Journal
                Sci Adv
                Sci Adv
                sciadv
                advances
                Science Advances
                American Association for the Advancement of Science
                2375-2548
                March 2023
                10 March 2023
                : 9
                : 10
                : eade1285
                Affiliations
                [ 1 ]Biological Science Division, Pacific Northwest National Laboratory, Richland, WA 99354, USA.
                [ 2 ]Biosciences Division, Oak Ridge National Laboratory, One Bethel Valley Road, Oak Ridge, TN 37831, USA.
                [ 3 ]Bredesen Center for Interdisciplinary Research, University of Tennessee, Knoxville, TN 37996,USA.
                [ 4 ]Plant and Microbial Biology Department, University of California, Berkeley, CA 94701, USA.
                [ 5 ]Plant Gene Expression Center, USDA-ARS, Albany, CA 94710, USA.
                Author notes
                [* ]Corresponding author. Email: robert.egbert@ 123456pnnl.gov (R.G.E.); gussam@ 123456ornl.gov (A.M.G.).
                Author information
                https://orcid.org/0000-0003-4750-9640
                https://orcid.org/0000-0002-1690-5723
                https://orcid.org/0000-0001-7159-3075
                https://orcid.org/0000-0003-0776-8664
                https://orcid.org/0000-0002-3964-6090
                https://orcid.org/0000-0001-6761-8575
                https://orcid.org/0000-0003-4656-7793
                https://orcid.org/0000-0002-6282-1731
                https://orcid.org/0000-0001-5823-5329
                https://orcid.org/0000-0002-9470-7124
                Article
                ade1285
                10.1126/sciadv.ade1285
                10005180
                36897939
                54b07461-9cd9-4ff6-999e-257d8e3b98b8
                Copyright © 2023 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).

                This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license, which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.

                History
                : 15 August 2022
                : 01 February 2023
                Funding
                Funded by: FundRef http://dx.doi.org/10.13039/100000015, U.S. Department of Energy;
                Award ID: Persistence Control Science Focus Area
                Funded by: FundRef http://dx.doi.org/10.13039/100000015, U.S. Department of Energy;
                Award ID: Agile BioFoundry
                Funded by: FundRef http://dx.doi.org/10.13039/100000015, U.S. Department of Energy;
                Award ID: Center for Bioenergy Innovation
                Funded by: FundRef http://dx.doi.org/10.13039/100000185, Defense Advanced Research Projects Agency;
                Award ID: HR0011045664
                Categories
                Research Article
                Biomedicine and Life Sciences
                SciAdv r-articles
                Microbiology
                Synthetic Biology
                Synthetic Biology
                Custom metadata
                Nicole Falcasantos

                Comments

                Comment on this article